Vadadustat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Vadadustat. Educational only — not medical advice.
Labeled uses
VAFSEO is indicated for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months. Limitations of Use VAFSEO has not been shown to improve quality of life, fatigue, or patient well-being. VAFSEO is not indicated for use: As a substitute for red blood cell transfusions in patients who require immediate correction of anemia In patients with anemia due to CKD not on dialysis [see Warnings and Precautions (5.6 )] .
Source: FDA labeling via NIH DailyMed (set ac9da724…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.